Diisopropylethylamine → HCID 71494104, 화합물
반응식
[C:1]([N:5]1[C:9]([C:10]2[CH:15]=[CH:14][C:13]([F:16])=[CH:12][CH:11]=2)=[C:8]([C:17]2[S:18][CH:19]=[C:20]([CH2:22][C:23](O)=[O:24])[N:21]=2)[CH:7]=[N:6]1)([CH3:4])([CH3:3])[CH3:2].CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.CCN(C(C)C)C(C)C.[N:59]1([C:64]2[CH:71]=[CH:70][C:67]([CH2:68][NH2:69])=[CH:66][CH:65]=2)[CH:63]=[CH:62][N:61]=[CH:60]1>CN(C=O)C.O>[C:1]([N:5]1[C:9]([C:10]2[CH:11]=[CH:12][C:13]([F:16])=[CH:14][CH:15]=2)=[C:8]([C:17]2[S:18][CH:19]=[C:20]([CH2:22][C:23]([NH:69][CH2:68][C:67]3[CH:66]=[CH:65][C:64]([N:59]4[CH:63]=[CH:62][N:61]=[CH:60]4)=[CH:71][CH:70]=3)=[O:24])[N:21]=2)[CH:7]=[N:6]1)([CH3:3])([CH3:2])[CH3:4]참가 물질
7
반응물 4
생성물 1
시약·촉매·용매 2
실험 절차
A solution of 2-(2-(1-tert-butyl-5-(4-fluorophenyl)-1H-pyrazol-4-yl)thiazol-4-yl)acetic acid (50 mg, 0.14 mmol), HATU (106 mg, 0.28 mmol), DIEA (0.049 mL, 0.28 mmol) and 4-(1H-imidazol-1-yl)benzylamine (96 mg, 0.56 mmol) in DMF (2.0 mL) was stirred at room temperature for 14 hr. Water was added to the reaction solution, and the mixture was extracted with ethyl acetate. The organic layer was washed with water and saturated brine and dried, and the solvent was evaporated under reduced pressure. The obtained residue was purified by NH-silica gel column chromatography (solvent gradient; 50→70% ethyl acetate/hexane) to give the title compound (33.4 mg, 0.065 mmol, 46.7%) as a white powder.
후처리
- extractionthe mixture was extracted with ethyl acetate
- washThe organic layer was washed with water and saturated brine
- customdried
- customthe solvent was evaporated under reduced pressure
- customThe obtained residue was purified by NH-silica gel column chromatography (solvent gradient; 50→70% ethyl acetate/hexane)
출처 및 근거
- ORD 기록
- ord-3964f14674b84959887286e6e85dd0b9
- 출처 데이터셋
- uspto-grants-2015_10
- 특허 번호
- US09156837B2
반응 노트
불러오는 중…